A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease
Clinical trial NCT05890001 · COMPLETED
Trial details
- NCT number
- NCT05890001
- Sponsor
- Braintree Laboratories
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-05
- Primary completion
- 2024-10-08
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.